Acellular versus Whole-Cell Pertussis Vaccines

Acellular versus Whole-Cell Pertussis Vaccines

Saved in:

Bibliographic Details
Main Authors:	S Halperin, DE Scheifele, NE MacDonald
Format:	Article
Language:	English
Published:	Wiley 1992-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1992/564683
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines
by: C. Buddy Creech, et al.
Published: (2025-08-01)

Systems biology-based assessment of immune responses to whole cell and acellular pertussis vaccines
by: Mariana Leguia, et al.
Published: (2025-08-01)

Risk of Brain Damage Following Pertussis Immunization with Whole-Cell cf Acellular Vaccines
by: J Gordon Millichap
Published: (2004-06-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01)

Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis
by: Mieszko M. Wilk, et al.
Published: (2019-01-01)

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
by: E. M. Zaitsev, et al.
Published: (2017-04-01)

Acellular Pertussis Vaccine from Antigens of Freshly Isolated and Vaccine Strains of Bordetella pertussis with Different Genotypic Characteristics
by: E. M. Zaitsev, et al.
Published: (2021-09-01)

Adult pertussis in the acellular-cell vaccine era: Comparative analysis of pertussis toxin antibodies in hospitalized patients with prolonged cough
by: Mengyang Guo, et al.
Published: (2025-12-01)

Evaluation of Immune Responses to Tdap Booster During Pregnancy in Women Who Received Whole Cell or Acellular Pertussis Vaccines During Childhood
by: Jesse M. Hall, et al.
Published: (2025-08-01)

Evaluation of acellular pertussis vaccine: comparisons among different strains of mice
by: Jie Wei, et al.
Published: (2023-12-01)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008-01-01)

Safety of Combination Vaccines with Whole Cell Pertussis Component
by: O. V. Perelygina, et al.
Published: (2016-12-01)

Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama
by: Arlene E. Calvo, et al.
Published: (2024-12-01)

Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection
by: Karolína Škopová, et al.
Published: (2025-04-01)

Humoral immunity to adhesins and toxins of the pertussis pathogen in mice immunized with experimental acellular pertussis vaccines from biofilm and planktonic cultures of <i>Bordetella pertussis</i>
by: Evgeny M. Zaitsev, et al.
Published: (2025-05-01)

Development and Implementation of a Single Radial Diffusion Technique for Quality Control of Acellular Pertussis Vaccines
by: Chongyang Wu, et al.
Published: (2025-01-01)

Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020–2023
by: Zhen Li, et al.
Published: (2025-12-01)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
by: Aapo Knuutila, et al.
Published: (2023-12-01)

Moving Towards a Universal Hepatitis B Vaccine Program for Canadian Children
by: NE MacDonald
Published: (1995-01-01)

Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in mice
by: Yetunde Adewunmi, et al.
Published: (2025-05-01)

Influence of storage conditions on the toxicity of whole-cell pertussis vaccine in outbred mice
by: I. A. Alekseeva, et al.
Published: (2025-04-01)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011-02-01)

Office Diagnosis of Pertussis
by: Scott Halperin
Published: (1992-01-01)

Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine
by: Azadeh Safarchi, et al.
Published: (2019-01-01)

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy
by: Bahaa Abu-Raya, et al.
Published: (2025-05-01)

Impact of acellular immunization against pertussis; comparative experience of four countries in North, Central and South America
by: María L. Ávila-Agüero, et al.
Published: (2025-12-01)

Pertussis Immunization for Adolescents: What Are We Waiting for?
by: SA Halperin
Published: (2001-01-01)

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
Published: (2020-03-01)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015
by: Alba Mir-Cros, et al.
Published: (2019-01-01)

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study
by: Melina Thibault, et al.
Published: (2024-12-01)

Pertussis in Children in an Era of Vaccination
by: Alison Marion Snodgrass, et al.
Published: (2019-01-01)

Safety of pertussis vaccines for adolescents
by: M. P. Kostinov, et al.
Published: (2020-10-01)

Reactogenicity to a Live Attenuated Varicella Vaccine in Canadian Children
by: Francisco Diaz-Mitoma, et al.
Published: (2000-01-01)

PROTECTIVE EFFICACY OF PERTACTIN CONTAINING ACELLULAR DPT VACCINES
by: M.V. Fesenko, et al.
Published: (2008-04-01)

PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
by: A. Yu. Kulikov, et al.
Published: (2014-11-01)

Pertussis models to inform vaccine policy
by: Patricia T Campbell, et al.
Published: (2015-03-01)

Pertussis in the Voronezh Region: Epidemiology and Vaccination
by: N. P. Mamchik, et al.
Published: (2020-05-01)

VACCINES FOR PERTUSSIS PREVENTION (WHO POSITION)
by: article editorial
Published: (2008-01-01)

Pertussis vaccination: problems, possible solutions
by: S. M. Kharit, et al.
Published: (2020-06-01)

Infantile Epileptic Spasms Syndrome in an Infant with PHACTR1 Mutation Triggered by Whole-Cell-Pertussis Vaccine: A Case Report with Review of Literature
by: Sreejana Sharma, et al.
Published: (2025-01-01)